|1.||Neamati, Nouri: 2 articles (01/2015 - 01/2014)|
|2.||Sechi, Mario: 2 articles (01/2015 - 01/2014)|
|3.||Pathania, Divya: 2 articles (01/2015 - 01/2014)|
|4.||Kuang, Yuting: 1 article (01/2015)|
|5.||Palomba, Michele: 1 article (01/2014)|
|6.||Taheri, Laleh: 1 article (01/2014)|
|7.||Sanna, Vanna: 1 article (01/2014)|
|8.||Berrettini, Francesco: 1 article (01/2014)|
|9.||Sias, Angela: 1 article (01/2014)|
|10.||Lee, K T: 1 article (08/2013)|
01/01/2014 - "In conclusion, our novel quinazolinediones are promising lead compounds that selectively induce ROS-mediated cell death in cancer cells and warrant further preclinical studies. "
08/01/2013 - "Molecular modelling, synthesis, cytotoxicity and anti-tumour mechanisms of 2-aryl-6-substituted quinazolinones as dual-targeted anti-cancer agents."
04/01/2012 - "Quinazolinones-based compounds have ability to suppress prostate tumor growth via apoptosis. "
08/01/2008 - "A new series of thirteen 2-[3-(substituted amino)-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl]-3-phenyl-4(3H)-quinazolinones 4-16 were prepared in order to evaluate their cytotoxic activity against 12 human cancer cell lines. "
|2.||Pancreatic Neoplasms (Pancreatic Cancer)
02/28/2008 - "Quinazolinones 8 and pyrido[3,4-d]pyrimidin-4-ones 9 as orally active and specific matrix metalloproteinase-13 inhibitors were discovered for the treatment of osteoarthritis. "
02/28/2008 - "Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis."
01/01/2005 - "The effects of different quinazolinones and bezafibrate on reduction of serum LDL-C level were comparable in single hypercholesterolemia but significantly different in combined hypercholesterolemia. "
01/01/2005 - "Treatment of rats with single and combined hypercholesterolemia with quinazolinone compounds gave rise to highly significant reductions in serum total cholesterol and cholesterol ester levels, whereas serum triacylglycerol level was significantly reduced only after treatment with halogen-substituted quinazolinones in single hyper-cholesterolemia, compared to the control group. "
|5.||Dehydration (Water Stress)
|1.||Matrix Metalloproteinase 13
|2.||Reactive Oxygen Species (Oxygen Radicals)
|6.||anthranilic acid (anthranilate)